Bayer AG (BAYRY)
14.25
-0.09
(-0.63%)
USD |
OTCM |
Aug 26, 16:00
Bayer EPS Diluted (Quarterly) : 0.0648 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0648 |
| March 31, 2026 | 0.8226 |
| December 31, 2025 | -1.113 |
| September 30, 2025 | -0.2864 |
| June 30, 2025 | -0.0574 |
| March 31, 2025 | 0.3479 |
| December 31, 2024 | -0.0909 |
| September 30, 2024 | -1.169 |
| June 30, 2024 | -0.0093 |
| March 31, 2024 | 0.5524 |
| December 31, 2023 | 0.3659 |
| September 30, 2023 | -1.265 |
| June 30, 2023 | -0.5226 |
| March 31, 2023 | 0.5947 |
| December 31, 2022 | 0.1586 |
| September 30, 2022 | 0.1399 |
| June 30, 2022 | -0.0807 |
| March 31, 2022 | 0.9395 |
| December 31, 2021 | 0.3377 |
| September 30, 2021 | 0.0255 |
| June 30, 2021 | -0.7158 |
| March 31, 2021 | 0.6403 |
| December 31, 2020 | 0.0934 |
| September 30, 2020 | -0.8161 |
| June 30, 2020 | -2.676 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4174 |
| December 31, 2019 | 0.3985 |
| September 30, 2019 | 0.2931 |
| June 30, 2019 | 0.1156 |
| March 31, 2019 | 0.3594 |
| December 31, 2018 | -1.200 |
| September 30, 2018 | 0.8517 |
| June 30, 2018 | 0.2583 |
| March 31, 2018 | 0.6773 |
| December 31, 2017 | 0.0492 |
| September 30, 2017 | 1.286 |
| June 30, 2017 | 0.3736 |
| March 31, 2017 | 0.6267 |
| December 31, 2016 | 0.1415 |
| September 30, 2016 | 0.3941 |
| June 30, 2016 | 0.464 |
| March 31, 2016 | 0.4964 |
| December 31, 2015 | 0.1993 |
| September 30, 2015 | 0.3309 |
| June 30, 2015 | 0.3828 |
| March 31, 2015 | 0.4462 |
| December 31, 2014 | 0.083 |
| September 30, 2014 | 0.3261 |
| June 30, 2014 | 0.388 |
| March 31, 2014 | 0.5794 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck KGaA | 0.2621 |
| Breakthrough Chemistry, Inc. | -0.1113 |
| Cardiac Biotech Solutions, Inc. | -0.0008 |
| Fresenius SE & Co. KGaA | 0.1971 |
| Carl Zeiss Meditec AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 266.26M |
| Revenue (Quarterly) | 12.64B |
| Total Expenses (Quarterly) | 12.39B |
| Enterprise Value | 95.17B |
| Gross Profit Margin (Quarterly) | 58.24% |
| Profit Margin (Quarterly) | 2.11% |
| Earnings Yield | -3.59% |
| Operating Earnings Yield | 13.06% |
| Normalized Earnings Yield | 3.466 |